CANLI
Yükleniyor Veriler getiriliyor…
SCI-Expanded Özgün Makale Scopus
Atherogenic index of plasma and triglycerideglucose index to predict more advanced coronary artery diseases in patients with the first diagnosis of acute coronary syndrome.
European Review for Medical & Pharmacological Sciences 2023 Cilt 27 Sayı 9
Scopus Eşleşmesi Bulundu
18
Atıf
27
Cilt
3993-4005
Sayfa
Özet
OBJECTIVE: Coronary heart disease (CHD) is the most common cause of mortality and morbidity. Acute coronary syndrome (ACS) is the most advanced form of the CHD spectrum. The triglyceride-glucose index (TGI) and atherogenic plasma index (AIP) are associated with future cardiovascular events. This study investigated the association of these parameters with the severity of CAD and prognosis in the first-diagnosed ACS patients. PATIENTS AND METHODS: Our study was designed retrospectively, including 558 patients. Patients were divided into four subgroups: high and low TGI and high and low AIP. SYNTAX scores, in-hospital mortality, major adverse cardiac events (MACE), and survival were compared at 12-month follow-up. RESULTS: More three-vessel disease and higher SYNTAX scores have been detected in the high AIP and TGI groups. More MACEs have been observed in high AIP and TGI groups than low groups. AIP and TGI were found to be independent predictors for SYNTAX ≥23. While AIP has been found to be an independent risk factor for MACE, TGI has not been detected as an independent risk factor. In addition to AIP, age, three-vessel disease, and lower EF were the independent risk factors for MACE. Survival was lower in high TGP and AIP groups. CONCLUSIONS: AIP and TGI are costless bedside parameters that can be easily calculated. These parameters can predict the severity of CAD in first-diagnosed ACS patients. Besides, AIP is an independent risk factor for MACE. AIP and TGI parameters can guide our treatment in this patient population.

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 18.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi Otomatik ISSN Eşleştirmesi 2023 yılı verileri
European Review for Medical and Pharmacological Sciences (discontinued)
Q2
SJR Quartile
0,580
SJR Skoru
97
H-Index
🔓
Açık Erişim
Kategoriler: Medicine (miscellaneous) (Q2) · Pharmacology (medical) (Q2)
Alanlar: Medicine
Ülke: Italy · Verduci Editore s.r.l
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir. Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.

Anahtar Kelimeler

Bu makale için anahtar kelime bilgisi bulunmuyor.

Makale Bilgileri

Dergi European Review for Medical & Pharmacological Sciences
ISSN 1128-3602
Yıl 2023 / 5. ay
Cilt / Sayı 27 / 9
Makale Türü Özgün Makale
Hakemlik Hakemli
Endeks SCI-Expanded
Teşvik Puanı 0,35 · YÖKSİS Akademik Teşvik
Yayın Dili İngilizce
Kapsam Uluslararası
Toplam Yazar 13 kişi
Erişim Türü Basılı+Elektronik
Alan Sağlık Bilimleri Temel Alanı Kardiyoloji

YÖKSİS Yazar Kaydı

Yazar Adı ÖZEN YASİN, Özbay Mustafa Bilal, YAKUT İDRİS, KANAL YÜCEL, abdelmottelaeb wael, NRİAGU BEDE, SALMON JAMES, QUINTANILLA BRYANN, MUNGUİA CESAR, REYES TİAGO, SHERPALLY DEEPAK, ERTEM AHMET GÖKTUĞ, YAYLA ÇAĞRI
YÖKSİS ID 7738636

Metrikler

Scopus Atıf 18
Havuz Atıfları 0
Teşvik Puanı 0,35
Yazar Sayısı 13